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IT was demonstrated previously that mice undergoing
an inflammatory reaction induced by subcutaneous (SC)
implantation of copper rods, produce humoral factors
that initially enhance, but subsequently inhibit, diffusion
chamber (DC) granulopoiesis. This provided evidence
that granulopoiesis is under the control of both humoral
stimulators and inhibitors. In order to test the granulo-
poietic regulatory mechanism in leukaemic mice, we
investigated the regulatory role of granulopoietic humoral
inhibitors during in vivo granulopoiesis. We noticed that
mice suffering from acute myeloid leukaemia (AML) are
unable to augment the production of these humoral in-
hibitory factors when acute inflammation is induced, since
no change inDC cell content was observed with or without
prior inflammation. Moreover, unlike healthy mice, the
serum of leukaemic mice withdrawn during the inhibition
phase of acute inflammation did not show any inhibitory
activity toward granulocytemonocyte (GM) colony
growth in vitro. Our results also show that increased
levels of normal humoral inhibitors do not influence the
proliferation and/or differentiation of leukaemic cells im-
planted in diffusion chamber cultures.
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Control of in vivo granulopoiesis by humoral
factors is difficult to study for several reasons.
Among these reasons are the lack of a satisfactory
label for newly released granulocytes, and the
emptying of important intramedullary storage pools
by injection of foreign proteins. For these reasons,
several investigators have used the in vivo
intraperitoneal diffusion chamber (DC) culture
technique. This technique allows proliferation and
differentiation of nearly all types of haemopoietic
cells, and shows that in vivo haemopoietic cell
proliferation and differentiation are under the
control of humoral regulators. Under states of
increased demand, such as acute inflammation, DC
granulopoiesis was regulated by both granulopoie-
tic humoral stimulators and inhibitors.
2 When DCs,
loaded with a constant number of murine bone
marrow cells, are implanted into mice that were
stimulated the previous day by an aseptic abscess,
significantly more proliferative and non-prolifera-
tive granulocytes, as well as their progenitors,
develop in DC. However, when DCs are implanted
6 days after the induction of acute inflammation, a
significant depression of DC granulopoiesis is
observed.
2 This suggests that the release of both
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humoral granulopoietic stimulators and inhibitors
occurs consecutively.
The physiological granulopoietic regulatory
mechanism in states of increased demand is not clear
in leukaemic subjects, and the failure of normal
granulopoiesis in leukaemic hosts is not well
understood. However, recent investigations
3
showed that leukaemic mice are unable to
overproduce humoral granulopoietic stimulators
during the stimulation phase of acute inflammation.
The increased levels of these stimulators do not
influence either the proliferation or the differentia-
tion of leukaemic cells implanted in DC.
In the present study we investigated the
inflammatory response of leukaemic mice during
the inhibition phase of acute inflammation, in order
to examine the ability of the leukaemic host to
produce physiological granulopoietic inhibitors. In
addition, we examined the effect of normal humoral
granulopoietic inhibitors on leukaemic cell differ-
entiation and proliferation.
Materials and Methods
Mice: Male CBA/H mice (Centre d’animaux de
laboratoire, Heverlee, Belgium) 16-18 weeks of age,
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were used as host animals for the diffusion chamber
cultures and as a source for adult normal and
leukaemic bone marrow cells.
Induction of acute inflammation: Acute inflammation
followed by an aseptic abscess formation was
induced by subcutaneous insertion of metallic
copper rods under sterile conditions as previously
described.
2 A surgical incision was made in the left
paravertebral area in control mice (sham operation)
to exclude non-specific effects of surgery on
haemopoiesis.
Induction of acute myeloid leukaemia (AML): Acute
myeloid leukaemic cells were obtained from the
spleen of CBA/H leukaemic mice (Radiobiology
Unit, Harwell, Didcot, Oxon, UK). AML was
induced by ionizing radiation4 and maintained by
serial intravenous inoculation into new CBA/H
mice as previously described. Each host CBA/H
mouse was injected intravenously with 0.2 ml of
suspension medium containing one million leukae-
mic splenic cells, 8 days prior to copper insertion.
The suspension medium was Hanks’s Balanced Salt
Solution (HBSS) with 10% fetal calf serum.
Diffusion chamber cultures: DCs were prepared accord-
ing to Benestad.
6 Briefly, two DCs were filled with
0.1 ml Alpha Modified Essential Medium (0-MEM)
containing 5 x 105 murine bone marrow cells.
These DCs were implanted in the peritoneal cavity
of each host mouse 6 days after inflammation
induction or sham operation, for a 3-day period.
Then the DCs were removed and agitated for 1 h
in 0-MEM containing 5% Ficoll and 0.5% pronase
to dissolve any fibrin clot. The contents were
harvested as described by Tyler et al.V Direct smears,
differential counts and cell classification were
performed as previously described.
8
In the first part of the experiment, DCs were
loaded with normal bone marrow cells and
implanted in healthy and leukaemic mice, both
challenged with aseptic abscesses, in order to
examine the humoral regulatory system in each
group. In the second part of the experiment, DCs
loaded with leukaemic cells were implanted in
healthy mice alone, with and without aseptic
abscesses, in order to examine the leukaemic cell
response to humoral regulators.
Assay for colony stimulating activity: Sera obtained from
host mice were pooled and assayed for their ability
to inhibit the growth of haemopoietic colonies in
agar gel. Serum colony inhibitory activity was
expressed by the reduction in the mean number of
colonies produced by mixing 0.03 ml of tested
serum with 0.13 ml horse serum when 105 bone
marrow cells were seeded. The number of
granulocytemonocyte colony forming units
(CFU-GM) was determined in agar by a modified
version that has been described previously.9’1
Pokeweed mitogen-stimulated spleen cell condi-
tioned medium (PWM-SCM) was prepared as
previously described,
11 and added in all experiments
to a final concentration of 20%. Colonies were
counted on day 5 of culture. Three to five plates
were counted for each experimental point.
Statistics: Results are expressed as means -t- standard
error of the means (SEM). Mann--Whitney’s U test
was used to assess the statistical significance
between two comparable experimental groups, and
the Kruskal--Wallis test was used to assess
statistical significance between more than two
groups.
Results
Diffusible granulopoietic inhibitor release in healthy and
leukaemic mice" Normal murine bone marrow cells
were cultured in DCs implanted intraperitoneally
both in normal and leukaemic hosts 6 days after
copper insertion or sham operation. Three days
after DC implantation we observed that, in healthy
mice, DC cell growth was lower in the copper-
inserted group than in the sham-operated mice
(104.496-t- 11.157, 167.849 _-t- 14.608, respectively;
p < 0.025, Figure 1). However, DC cell growth rate
was not changed in leukaemic hosts with or without
copper insertion (150.983 -t- 11.890, 144.246 -t-
12.309, respectively; p > 0.2, Figure 1). Moreover,
the growth rate of DC granulocytes was signifi-
cantly higher in leukaemic hosts when compared
to healthy mice during the inhibition phase of acute
inflammation (p < 0.025).
Changes in proliferative and non-proliferative
granulocytes and in macrophages are shown in
w 1-
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FIG. 1. The effect of acute inflammation inhibition phase on DC
granulopoiesis in healthy and leukaemic hosts. Four groups of mice were
studied" in each group (minimum three mice) at least six DCs were
analysed for each experiment. The results are expressed as mean ___
SEM
for three experiments.
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Table 1. The differential growth of normal murine bone marrow cells implanted into
diffusion chambers. Cells were harvested on the third day of culture. The results represent
mean values _+ SEM from three experiments
Granulocyte/DC
Host condition Proliferative Non-proliferative Macrophages
Healthy mice
Sham-operated controls 78.829 ___
7.614 38.216 _+ 4.942 40.837 _+ 6.878
Copper-inserted mice 48.842 + 4.988 28.480 +_ 3.844 27.342 _+ 4.382
Leukaemic mice
Sham-operated controls 68.432 _+ 5.882 33.876 _+ 4.128 31.488 _+ 4.672
Copper-inserted mice 70.864 _+ 7.134 36.684 _+ 4.855 34.460 _+ 4.825
Table 1. The production of both proliferative and
non-proliferative granulocytes and of macrophages,
is lower in DC implanted in copper-inserted healthy
mice than in sham-operated controls (p < 0.025).
However, in leukaemic copper-inserted hosts these
numbers remained equal to those observed in
sham-operated leukaemic controls (p > 0.2). These
data indicate that humoral granulopoietic inhibitor
release is demonstrable in healthy but not in
leukaemic mice.
Serum colony inhibitory activity in healthy and
leukaemic mice" Serum of sham-operated healthy
controls permitted in vitro growth of 63 q-9
CFU-GM, while serum of copper-inserted healthy
mice during the inhibition phase of acute
inflammation (6 days after copper insertion)
permitted growth of 17 +/- 5 CFU-GM. This stat-
istically significant difference (p < 0.01) indicates
that serum of copper-inserted mice contains an
inhibitor to in vitro growth of granulocyte
monocyte colonies. However, in leukaemic hosts,
copper insertion did not change serum levels of
inhibitors (p > 0.2, Table 2).
Leukaemic cell response to humoral inhibitors" AML
cells were implanted in DCs in healthy mice
during the inhibition phase of acute inflammation.
No change in DC leukocyte number was
Table 2. Serum G M-colony growth inhibitor production in
healthy and leukaemic mice during the inhibition phase of acute
inflammation. Each value represents the mean __+ SEM for three
experiments. The serum was pooled, six days after the induction
of inflammation, from five to eight mice in each group. Inhibitory
activity was expressed as the mean number of CFU-GM colonies
in agar gel.
Host condition CFU-G M/105 cultured
bone marrow cells
Healthy mice
Sham-operated controls 63 _+ 9
Copper-inserted mice 17 -t- 5
Leukaemic mice
Sham-operated controls 72 __
11
Copper-inserted mice 74 +_ 12
observed compared to the control (p > 0.2, Figure
2). This shows the lack of leukaemic cell response
to humoral inhibitors,. Moreover, the growth rate
of leukaemic cells in DC was significantly higher
than the growth rate of normal cells (p < 0.01),
irrespective of prior inflammation. DC differential
cell counts showed no change in maturation state
ofDC leukaemic cells implanted in copper-inserted
mice. The number of blasts in DC implanted in
copper-inserted mice was 156.432_ 64.384, while
the number of blasts in DC implanted in
sham-operated hosts was 155.464 --t-_ 48.212 (p >
0.2).
Discussion
The induction of acute inflammation in healthy
mice by subcutaneous insertion of sterile metallic
copper rods, is associated with myeloid hyperplasia
and a significant increase in the levels of serum
colony stimulating factors (CSF), as well as an
3- NORMAL CELLS LEUKEMIC CELLS
"F"
CONTROL INFLAMMATION CONTROL INFLAMMATION
3 DAYS OF CULTURE IN DC
FIG. 2. The effect of acute inflammation inhibition phase on both DC
leukaemic and normal cell growth. DCs were implanted in four groups
of healthy mice" in each group (minimum three mice) at least six DCs
were analysed for each experiment. The results are expressed as
mean ___
SEM for three experiments.
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enhancement of DC granulopoiesis. 2’12’13 However,
6 days after induction of inflammation, the
DC-granulopoiesis is inhibited, suggesting that
diffusible granulopoietic humoral inhibitors are
released,2’14 and indicating a negative feedback
control of in vivo granulopoiesis. Investigating the
release of these humoral regulators in a leukaemic
host is of special interest, as testing the capability
of a leukaemic host to produce these factors
might explain, in part, the mechanism of normal
granulopoiesis failure in leukaemic subjects. Recent
investigations
3 showed that leukaemic mice are
unable to overproduce granulopoietic humoral
stimulators during the stimulation phase of acute
inflammation.
In this study we examined the humoral
response of leukaemic mice during the inhibition
phase of acute inflammation. The growth rate of
normal DC-granulocytes implanted in leukaemic
hosts proceeded to the same limiting concentrations
with or without prior inflammation. This suggests
that either leukaemic hosts are again unable to
overproduce humoral granulopoietic inhibitors, or
these inhibitors are functioning in vivo in an
improper manner. However, several investigators
have shown that leukaemic cells produce inhibitory
substances which suppress normal granulopoie-
sis.s’6 The possibility that the level of these
inhibitory substances is almost maximum in
leukaemic mice has been excluded, as the number
of DC cells is even higher in leukaemic mice when
compared to healthy mice during the inhibition
phase.
In vitro growth of haemopoietic cells is
stimulated by a group of glycoproteins, of
different molecular weights, called the colony
stimulating factors (CSF).
7 Our previous studies
12
showed that during the stimulation phase of acute
inflammation the level of CSF is significantly high
in the serum of normal mice. This is consistent
with the increased levels of granulopoietic stimula-
tors that enhance DC granulopoiesis in this phase
of acute inflammation. In this study we investigated
the presence of granulopoietic colony inhibitors in
the serum of the host mice during the inhibition
phase of acute inflammation. We observed that the
serum of non-leukaemic mice contains inhibitory
activity to granulocytic colony growth in vitro. This
activity is not demonstrable in the serum of
leukaemic mice challenged or non-challenged with
inflammation. It is not known yet whether the
inhibitory activity in the serum that acts on in vitro
granulocytic growth, and the humoral granulopoie-
tic inhibitor that depresses DC-granulocyte number
in vivo, represents one or several factors. Their
relationship to the previously described in vitro
inhibitors, such as lactoferrin,
18 monocyte prosta-
glandin,
9 colony-stimulating activity inhibitors,
2
and the transforming growth factor beta (TGF-fl),
21
is also unclear. However, both of them are
produced in non-leukaemic mice but not in
leukaemic ones during the inhibition phase.
Recently, we showed that T-lymphocytes are
involved in the release of granulopoietic humoral
inhibitors, either directly or indirectly, by their
interaction with other accessory bone marrow
cells. 14 This raises the question of whether
T-lymphocyte functional disorder in AML explains
the lack of response in leukaemic mice during the
inhibition phase of acute inflammation.
Unlike the growth rate of normal DC cells, the
growth rate of leukaemic cells implanted into a
non-leukaemic environment is unaffected by the
rise in humoral inhibitor levels, as no change is
observed in granulocyte cell proliferation and
differentiation. The growth rate of leukaemic cells
in DC implanted in normal mice, with or without
prior inflammation, is significantly higher than the
growth of normal cells. This shows that extrinsic
physiological inhibitors are unable to reduce the
growth rate of murine leukaemic cells, which
proliferate irrespective of prior inflammation,
reflecting uncontrolled proliferation of the leukae-
mic cells. These observations support the view that
AML is the expression of an intrinsic cellular defect
and is consistent with the findings of other
investigators.
22 However, several studies showed
that certain growth factors could inhibit leukaemic
bone marrow cell growth in vitro, like TGF-fl,
2 the
leukaemia inhibitory factor,
2 and the granulocytic
chalone.24’2s Thus, it may be asked why leukaemic
cells respond to in vitro inhibitors and not to in vivo
humoral physiological inhibitors, but the answer is
not clear.
However, the nature of in vivo inhibitors that have
been released after the induction of inflammation,
and their relation to the specific purified in vitro
growth factors, is not known yet. They might be
different regulatory factors, or their concentrations
in in vivo normal physiological conditions may be
lower than in in vitro exploited concentrations.
Moreover, the colony stimulating factor receptor
expression by AML blast cells has been shown to
be weaker than that caused by the normal mature
granulocytes.2<27 This weakness in receptor expres-
sion could therefore be a possible explanation for
the lack of leukaemic cell response to increased or
decreased levels of physiological humoral factor
regulators after inflammation induction.
Other models of diffusion chamber granulopoie-
sis enhancement have been investigated in hosts
rendered neutropenic with myelotoxic drugs’28 or
irradiation. 29 This has been interpreted as evidence
for humoral influence on granulocyte production.
Nevertheless, because of the numerous effects of
myelotoxic drugs or irradiation, the changes
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leading to increased cell proliferation in DC
might be quite nonspecific. Moreover, diffusion
chamber granulopoiesis enhancement after en-
dotoxin administration3 will modify the host
environment and can also affect directly the
cellular content of DC. On the other hand, none
of these models showed that granulopoiesis
regulation in DC is under the influence of both
humoral stimulators and inhibitors, as the aseptic
abscess model showed. However, our findings are
in agreement with a previous study
31 in which
irradiation had been exploited as a stimulus to the
growth of normal granulocytic cells in DC, since
leukaemic cells proliferate equally well with or
without prior host irradiation.
In conclusion, our findings show that leukaemic
hosts are unable to respond properly to stimuli to
release humoral granulopoietic inhibitors. They
also show that leukaemic cells are not sensitive to
increased levels of physiological humoral inhibitors,
as neither their proliferation nor differentiation is
affected.
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